Internal Medicine Research Unit, Pfizer Inc, Cambridge, United States
Jincheng Pang
Internal Medicine Research Unit, Pfizer Inc, Cambridge, United States
Yoson Park
Internal Medicine Research Unit, Pfizer Inc, Cambridge, United States
Shoh Asano
Internal Medicine Research Unit, Pfizer Inc, Cambridge, United States
Yu-Chin Lien
Center for Research on Reproduction and Women's Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States; Division of Neonatology, Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, United States
John D Griffin
Internal Medicine Research Unit, Pfizer Inc, Cambridge, United States
Andrew Robertson
Drug Safety Research and Development, Pfizer Inc, Groton, United States
Alan Opsahl
Drug Safety Research and Development, Pfizer Inc, Groton, United States
Dinesh Hirenallur Shanthappa
Internal Medicine Research Unit, Pfizer Inc, Cambridge, United States
Youngwook Ahn
Medicine Design, Pfizer Inc, Cambridge, United States
Evanthia Pashos
Internal Medicine Research Unit, Pfizer Inc, Cambridge, United States
Rebecca A Simmons
Center for Research on Reproduction and Women's Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States; Division of Neonatology, Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, United States
Morris J Birnbaum
Internal Medicine Research Unit, Pfizer Inc, Cambridge, United States
From a forward mutagenetic screen to discover mutations associated with obesity, we identified mutations in the Spag7 gene linked to metabolic dysfunction in mice. Here, we show that SPAG7 KO mice are born smaller and develop obesity and glucose intolerance in adulthood. This obesity does not stem from hyperphagia, but a decrease in energy expenditure. The KO animals also display reduced exercise tolerance and muscle function due to impaired mitochondrial function. Furthermore, SPAG7-deficiency in developing embryos leads to intrauterine growth restriction, brought on by placental insufficiency, likely due to abnormal development of the placental junctional zone. This insufficiency leads to loss of SPAG7-deficient fetuses in utero and reduced birth weights of those that survive. We hypothesize that a ‘thrifty phenotype’ is ingrained in SPAG7 KO animals during development that leads to adult obesity. Collectively, these results indicate that SPAG7 is essential for embryonic development and energy homeostasis later in life.